Literature DB >> 20473890

Association between toll-like receptor expression and human papillomavirus type 16 persistence.

Ibrahim I Daud1, Mark E Scott, Yifei Ma, Stephen Shiboski, Sepideh Farhat, Anna-Barbara Moscicki.   

Abstract

The mechanisms involved in mucosal immune control of cervical human papillomavirus (HPV) infection remain ill defined. Because toll-like receptors (TLRs) are key players in innate immune responses, we investigated the association between TLR expression and viral persistence or clearance in young women with incident infections with oncogenic HPV types 16 or 51. Messenger RNA expression of TLR1, TLR2, TLR3, TLR4, TLR6, TLR7, TLR8 and TLR9 was measured by quantitative reverse transcription-PCR using human endocervical specimens, collected before and after viral acquisition, in a cohort well characterized for HPV infections. Wilcoxon rank sum test was used to compare the change seen from preinfection to incident infection between women who subsequently cleared infection with those who did not. HPV 16 infections that cleared were significantly (p < 0.05) associated with an increase in expression of the four viral nucleic acid-sensing TLRs (TLR3, TLR7, TLR8 and TLR9) as well as TLR2 upon viral acquisition. Similar associations were not observed for HPV 51. In women who subsequently cleared their HPV 16 infection, changes in TLR1, TLR3, TLR7 and TLR8 expression levels between preincident and incident visits were significantly correlated with parallel changes in the levels of interferon-α2, measured by immunoassay in cervical lavage specimens. This study suggests that dampened TLR expression in the cervical mucosa is a type-specific mechanism by which HPV 16 interferes with innate immune responses, contributing to viral persistence, and that TLR upregulation and resultant cytokine induction is important in subsequent viral clearance.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20473890      PMCID: PMC2952342          DOI: 10.1002/ijc.25400

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

Review 1.  Viral recognition by Toll-like receptors.

Authors:  Gregory M Barton
Journal:  Semin Immunol       Date:  2007-03-02       Impact factor: 11.130

2.  Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.

Authors:  Tobias Warger; Philipp Osterloh; Gerd Rechtsteiner; Melanie Fassbender; Valeska Heib; Beate Schmid; Edgar Schmitt; Hansjörg Schild; Markus P Radsak
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

3.  High-throughput real-time quantitative reverse transcription PCR.

Authors:  Angie L Bookout; Carolyn L Cummins; David J Mangelsdorf; Jean M Pesola; Martha F Kramer
Journal:  Curr Protoc Mol Biol       Date:  2006-02

Review 4.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Authors:  Gary Clifford; Silvia Franceschi; Mireia Diaz; Nubia Muñoz; Luisa Lina Villa
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

5.  TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

Authors:  Uzma A Hasan; Elizabeth Bates; Fumihiko Takeshita; Alexandra Biliato; Rosita Accardi; Veronique Bouvard; Mariam Mansour; Isabelle Vincent; Lutz Gissmann; Thomas Iftner; Mario Sideri; Frank Stubenrauch; Massimo Tommasino
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

6.  Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.

Authors:  Anuradha Rebbapragada; Charles Wachihi; Christopher Pettengell; Sherzana Sunderji; Sanja Huibner; Walter Jaoko; Blake Ball; Keith Fowke; Tony Mazzulli; Francis A Plummer; Rupert Kaul
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

7.  Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.

Authors:  Serena Chang; Angela Dolganiuc; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2007-06-26       Impact factor: 4.962

Review 8.  Immunobiology of HPV and HPV vaccines.

Authors:  Margaret Stanley
Journal:  Gynecol Oncol       Date:  2008-05       Impact factor: 5.482

9.  Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates.

Authors:  Jay A Lieberman; Anna-Barbara Moscicki; Jan L Sumerel; Yifei Ma; Mark E Scott
Journal:  Clin Vaccine Immunol       Date:  2007-10-31

10.  Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR.

Authors:  Beatrice Vitali; Ciro Pugliese; Elena Biagi; Marco Candela; Silvia Turroni; Gert Bellen; Gilbert G G Donders; Patrizia Brigidi
Journal:  Appl Environ Microbiol       Date:  2007-07-20       Impact factor: 4.792

View more
  59 in total

1.  Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Authors:  Carole Fakhry; Morgan A Marks; Robert H Gilman; Lilia Cabrerra; Pablo Yori; Margaret Kosek; Patti E Gravitt
Journal:  Cytokine       Date:  2013-09-07       Impact factor: 3.861

2.  The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.

Authors:  Shasha Yang; Lan Liu; Dongyuan Xu; Xiangdan Li
Journal:  Pathol Oncol Res       Date:  2018-09-13       Impact factor: 3.201

3.  The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection.

Authors:  Luis F Barroso
Journal:  Ther Adv Vaccines       Date:  2013-07

4.  Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Authors:  Mark E Scott; Yurii B Shvetsov; Pamela J Thompson; Brenda Y Hernandez; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Dien D Vo; Anna-Barbara Moscicki; Marc T Goodman
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

Review 5.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

6.  Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response.

Authors:  Mark E Scott; Yifei Ma; Sepideh Farhat; Anna-Barbara Moscicki
Journal:  Int J Cancer       Date:  2014-10-30       Impact factor: 7.396

Review 7.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

Review 8.  Targeting pattern recognition receptors in cancer immunotherapy.

Authors:  Nadège Goutagny; Yann Estornes; Uzma Hasan; Serge Lebecque; Christophe Caux
Journal:  Target Oncol       Date:  2012-03-08       Impact factor: 4.493

9.  Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.

Authors:  Lauri Jouhi; Neeta Datta; Suvi Renkonen; Timo Atula; Antti Mäkitie; Caj Haglund; Abdirisak Ahmed; Stina Syrjänen; Reidar Grénman; Eeva Auvinen; Sanna Lehtonen; Jaana Hagström
Journal:  Tumour Biol       Date:  2015-05-05

10.  Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Sepideh Farhat; Julie Jay; Evelyn Hanson; Susanna Benningfield; Janet Jonte; Cheryl Godwin-Medina; Robert Wilson; Stephen Shiboski
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.